Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals

1 Feb 2001

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Respiratory viral infections research
Share to Virology and Viral Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 11166884
DOI: 10.1016/s0264-410x(00)00419-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animalsPMID 11166884Read ↗

Recombinant Newcastle disease virus as a vaccine vectorSemantic proximity Read ↗

Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal diseaseSemantic proximity Read ↗

Exploring the Prospects of Engineered Newcastle Disease Virus in Modern VaccinologySemantic proximity Read ↗

Identification of a natural multi-recombinant of Newcastle disease virusSemantic proximity Read ↗

A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse geneticsSemantic proximity Read ↗

Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle diseaseSemantic proximity Read ↗

Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenzaSemantic proximity Read ↗

Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccinesSemantic proximity Read ↗

Evolutionary insights into the fusion protein of Newcastle disease virus isolated from vaccinated chickens in 2016 in EgyptSemantic proximity Read ↗

Emerging natural recombinant Marek's disease virus between vaccine and virulence strains and their pathogenicitySemantic proximity Read ↗

Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeysSemantic proximity Read ↗

Review of Poultry Recombinant Vector VaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.